In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus

Journal of Infectious Diseases

Volumn 182, Issue 3, 2000, Pages 955-959

  Taylor, Brad N ^a   Fichtenbaum, Carl ^b,c   Saavedra, Michael ^a   Slavinsky, Joseph ^a   Swoboda, Rolf ^a   Wozniak, Karen ^a   Arribas, Alfredo ^a   Powderly, William ^b   Fidel, Paul L ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FUNGUS GROWTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; VIRULENCE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, MICROBIAL; FEMALE; FLUCONAZOLE; HUMANS; MICE; MICE, INBRED CBA;

EID: 0033831755     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315768     Document Type: Article

References (15)

1. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome
2. Oral mycoses in HIV infection
3. Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection
4. Candida albicans: From commensal to pathogen
5. Putative virulence factors of Candida albicans
6. Refratory mucosal candidiasis in patients with human immunodeficiency virus infection
7. Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir
8. Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents
9. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors
10. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection
11. Mice immunized by primary vaginal C. albicans infection develop acquired vaginal mucosal immunity
12. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis
13. Hormonal factors in vaginal candidiasis in rats
14. Efficacy of D0870 treatment of experimental Candida vaginitis